Skip to content

Public FDA record

Z-1091-2026: Philips Azurion Systems with software versions R2.1.10 and R2.2.10. Includes the following label descript

Recall record Z-1091-2026 for PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1091-2026
Company in FDA record
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
FDA classification date
Jan 14, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Six (6) identified software issues which may result in the following: system keeps restarting, AMC triple drive, C-Partition of Suite PC running out of free space, system remains in continuous restart mode after the start-up, misalignment of Market Tool Overlay, and longitudinal positional error.

Source facts

Action
Philips notified consignees on about 12/12/2025 via certified mailing. Consignees were instructed to identify any affected systems on hand, circulate the noification to all users of the system for awareness, notify any recipients if the affected systems have been transferred to another organization, maintain the notification with documentation of the system until Philips completes the correction, and complete and return the response form provided. Philips also provided recommended actions for each issue, if encountered. Philips will address the identified issues by implementing a software update (R2.1.15 or R2.2.15) in all affected systems (FCO72200660 to 2.2.15, FCO72200672 to 2.1.15). Philips expects to have this software update released by Q4 2026 (subject to regulatory clearance). Local Philips representatives will contact each consignee to schedule a visit to install the software updates once available.
Initiated
2025-12-12
Root cause
Software design
Distribution
Worldwide distribution - US Nationwide and the countries of Afghanistan, Albania, Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Cambodia, Canada, Cayman Islands, Chile, China, Colombia, Costa Rica, C¿te D'Ivoire, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Ethiopia, Fiji, Finland, France, French Polynesia, Germany, Ghana, Gibraltar, Greece, Guadeloupe, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Korea, Republic of, Korea, South, Kosovo, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Libya, Lithuania, Macao, Macedonia, Malaysia, Maldives, Malta, Martinique, Mauritania, Mauritius, Mexico, Moldova, Mongolia, Morocco, Myanmar, Nepal, Netherlands, New Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Palestine, State of, Panama, Peru, Philippines, Poland, Portugal, Qatar, R¿union, Romania, Russian Fed., Russian Federation, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tanzania, Thailand, Tunisia, Turkey, Turkmenistan, Ukraine/United Arab Emirate, United Kingdom, Uruguay, Uzbekistan, Viet Nam, Vietnam, Yemen.
Recall number
Z-1091-2026
Recall status
Open, Classified
CDRH record ID
217611
FDA classified
2026-01-14
Recall event number
98096

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗